List of SBIR/STTR awards granted to Lexeo Therapeutics
Lexeo TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Lexeo Therapeutics in August, 2020 for $499,916.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41NS117265-01 | Phase I | 499,916 | August 1, 2020 | |||||||
A STTR Phase I contract was awarded to Lexeo Therapeutics in July, 2020 for $252,042.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AA028465-01 | Phase I | 252,042 | July 1, 2020 | |||||||
A STTR Phase II contract was awarded to Lexeo Therapeutics in June, 2019 for $1,499,103.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 4R42HL140670-02 | Phase II | 1,499,103 | June 1, 2019 | |||||||
A STTR Phase I contract was awarded to Lexeo Therapeutics in September, 2019 for $224,593.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41HL145871-01A1 | Phase I | 224,593 | September 23, 2019 | |||||||
A STTR Phase I contract was awarded to Lexeo Therapeutics in February, 2018 for $224,967.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R42HL140670-01 | Phase I | 224,967 | February 1, 2018 | |||||||
A STTR Phase I contract was awarded to Lexeo Therapeutics in June, 2019 for $224,970.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AA027739-01 | Phase I | 224,970 | June 1, 2019 |
